Senior insider sale
AMNEAL PHARMACEUTICALS, INC. — senior position signals high conviction
$2.92M
168.57K shares
What this filing means
BUCHI J KEVIN plans to sell 168.57K shares of AMNEAL PHARMACEUTICALS, INC. valued at approximately $2.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/11/2026ACC: 0001949846-26-000494
Director
Since May 2019
168.57K
Shares to sell
$2.92M
Approx. market value
180.34K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
Restricted Stock Award
Equity Compensation
5/5/2025
40.26KRestricted Stock Award
Equity Compensation
5/10/2024
76.45KRestricted Stock Award
Equity Compensation
5/5/2021
46.22KRestricted Stock Award
Equity Compensation
5/8/2019
6.11KRestricted Stock Award
Equity Compensation
5/3/2018
3.28KRestricted Stock Award
Equity Compensation
5/15/2017
8.02KTotal acquired180.34K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/5/2025 | Restricted Stock Award Equity Compensation | 40.26K | — |
5/10/2024 | Restricted Stock Award Equity Compensation | 76.45K | — |
5/5/2021 | Restricted Stock Award Equity Compensation | 46.22K | — |
5/8/2019 | Restricted Stock Award Equity Compensation | 6.11K | — |
5/3/2018 | Restricted Stock Award Equity Compensation | 3.28K | — |
5/15/2017 | Restricted Stock Award Equity Compensation | 8.02K | — |
| Total | 180.34K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
168.57K
Market value
$2.92M
8/11/2026
Total
Units
168.57K
Value
$2.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/11/2026 | 168.57K | $2.92M | Nasdaq | Planned |
| Total | 168.57K | $2.92M | ||